Effect of Sevoflurane on the Onset Characteristics and Intubating Conditions of Rocuronium

Phase 4 Completed 60 enrolled Maharashtra University of Health Sciences Jaslok Hospital and Research Centre · collab

RandomizedParallel-groupOpen-labelTreatment

Summary

This study evaluates the potentiation of muscle relaxation caused by rocuronium by inhalational agent sevoflurane. Half the patients will be ventilated with oxygen ,nitrous oxide and sevoflurane during induction of anaesthesia and half will be ventilated only with oxygen and nitrous oxide.

Timeline

Start: 2004-04
Primary completion: 2006-11
Completion: 2006-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Rocuronium	Other / unclassified	0.6 mg/kg	Intravenous
Subject	Sevoflurane	Other / unclassified	2 %	Inhaled

Indications

No indication recorded.